These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 23890557)

  • 1. Vitamin D in thyroid tumorigenesis and development.
    Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
    Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer.
    Clinckspoor I; Verlinden L; Overbergh L; Korch C; Bouillon R; Mathieu C; Verstuyf A; Decallonne B
    J Steroid Biochem Mol Biol; 2011 Mar; 124(1-2):1-9. PubMed ID: 21182945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.
    Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B
    J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
    Seuter S; Pehkonen P; Heikkinen S; Carlberg C
    Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
    Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
    Buchwald PC; Westin G; Akerström G
    Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-cancer actions of vitamin D.
    Chiang KC; Chen TC
    Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM; Schwartz GG; Woodruff R; Cramer SD
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
    Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
    Osborne JE; Hutchinson PE
    Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of High-Quality Spermatozoa May Be Promoted by Activated Vitamin D in the Woman.
    Bøllehuus Hansen L; Rehfeld A; de Neergaard R; Nielsen JE; Iversen LH; Boisen IM; Mortensen LJ; Lanske B; Almstrup K; Carlsen E; Berg AH; Jørgensen N; Andersen AN; Juul A; Blomberg Jensen M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):950-961. PubMed ID: 27977320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
    Nezbedova P; Brtko J
    Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.
    Ono Y
    J Steroid Biochem Mol Biol; 2014 Jan; 139():88-97. PubMed ID: 24139874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic mechanisms controlling renal vitamin D metabolism.
    Meyer MB; Pike JW
    J Steroid Biochem Mol Biol; 2023 Apr; 228():106252. PubMed ID: 36657729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.